Viewing nowCombinationSidaftbia Tablet 10/100 mg (Dapagliflozin, Sitagliptin)
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.

MFDS item code 202302010 · Approved 2023.06.30 · Insurance code 650701370
Improves blood glucose control in patients with type 2 diabetes mellitus
This medication is used in cases where sitagliptin and dapagliflozin are combined to assist in improving blood sugar control for patients with type 2 diabetes, along with dietary and exercise therapies. This helps facilitate effective blood sugar management.
This medicine may be administered as 1 tablet once daily, regardless of meals, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. Patients with renal impairment The efficacy and safety of this medicine depend on renal function. It is recommended that renal function be assessed before and periodically after administration of this medicine. - No dose adjustment is necessary when the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. - Do not administer this medicine when the estimated glomerular filtration rate (eGFR) is below 45 mL/min/1.73 m2. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication may cause allergic reactions, so it should not be used in case of hypersensitivity. Symptoms of acute pancreatitis may occur during the use of this medication. If you experience abdominal pain or vomiting, you must consult your doctor immediately. Patients with poor kidney function or low fluid levels must use this medication cautiously. Regular monitoring is needed as symptoms of low blood pressure or dehydration may appear. A serious metabolic disorder called diabetic ketoacidosis may occur, so treatment should be sought immediately if symptoms of ketoacidosis appear, regardless of blood sugar levels. This medication may increase the risk of genital and urinary tract infections; prompt treatment is required if infection symptoms occur. Elderly patients or those with reduced kidney function may need dosage adjustments, and regular kidney function tests are recommended. Pregnant or nursing women are advised not to use this medication, and it should be discontinued if pregnancy is confirmed. Hypoglycemia symptoms may occur during the use of this medication, especially when taken with insulin or other antihyperglycemic agents, so caution is advised. There is no specific antidote in case of overdose, so appropriate treatment should be given based on symptoms, and monitoring in a hospital may be necessary if needed. Caution is required when driving or operating machinery as symptoms may change after taking this medication, Store the medication out of reach of children and keep it in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent the ingress of air or moisture and keep it at room temperature between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness and safety.
Yellow, oval, biconvex film-coated tablets
28 tablets / box [(14 tablets / PTP × 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.